Page 24 - SaxoCell Annual Report22/23

SaxoCell projects

Allo-CAR-Treg Genetically modified regulatory T cells for
CAR- the treatment of autoimmune diseases
T UltraCART CAR-T cell approach with novel target
molecules and innovative technology
CAR-NK4.0 AI-assisted CAR-NK cell platform with fully
automated manufacturing process
CAR- CAReNK-AID CAR-NKs for the treatment of severe
NK autoimmune diseases

NK4Therapy Memory NK cell subset for tumor
immunotherapy

HemRec Designer recombinases for regenerative
therapy of hemoglobinopathies

ZellTWund Regenerative wound dressing from fibro-
Reg. blasts & biopolymers for chronic wounds
Med. Macrophages for allogeneic transplantation
xMac in solid tumors

MSC-PreStiGe Immunomodulatory mesenchymal stromal
cells against GvHD after transplantation

OPTIX Antibody-modified stem cell trans-
plantation for the prevention of GvHD
Mod. ECP-CAR Extracorporeal photophoresis as a modula-
ATMP tory adjunct in CAR-T cell therapy

TheraSTAR Switchable Uni-CAR receptors for therapy
& diagnostics

19